预防性地塞米松降低外周神经阻滞后反跳痛:系统评价、荟萃分析与试验序贯分析
该系统评价与荟萃分析纳入7项随机对照试验共574例成人手术患者,评估预防性地塞米松对外周神经阻滞后反跳痛的效果。地塞米松组反跳痛发生率显著降低(OR 0.16,95%CI 0.10-0.27,P=0.00,I2=0%),试验序贯分析证实信息量充足,静脉与神经周围给药亚组均显示显著降低。
要点
- 预防性地塞米松可显著降低外周神经阻滞后反跳痛发生率(OR 0.16)。
- 静脉给药与神经周围给药均可显著降低反跳痛发生率。
- 试验序贯分析证实该有益效应的信息量已充足。
核心结论
- 当前证据表明,静脉或神经周围给予地塞米松均可降低外周神经阻滞用于术后镇痛后的反跳痛发生率。
研究设计与样本
- 系统评价与荟萃分析,检索多种数据库并更新至2023年5月,纳入7项随机对照试验共574例成人手术患者。
主要发现
- 与对照组相比,地塞米松组反跳痛发生率降低,OR 0.16(95%CI 0.10-0.27,P=0.00,I2=0%)。
- 试验序贯分析证实地塞米松有益效应的信息量充足。
- 亚组分析显示静脉给药和神经周围给药均与反跳痛发生率显著降低相关。
关键数值与推荐
- 主要结局为反跳痛发生率;次要结局包括反跳痛严重程度与发作时间、疼痛控制满意度、疼痛所致睡眠障碍及地塞米松不良反应。
- 亚组分析基于给药途径(静脉或神经周围)对反跳痛发生率的影响进行。
临床怎么用
- 成人手术患者接受外周神经阻滞术后镇痛时,可考虑预防性使用地塞米松以降低反跳痛发生率,静脉或神经周围途径均可。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rebound pain occurs after the resolution of peripheral nerve block and hampers patient recovery in the postoperative period. We sought to synthesise available data from randomised controlled trials (RCTs) evaluating the efficacy of prophylactic dexamethasone for rebound pain in adult patients undergoing surgery with a peripheral nerve block. METHODS: In this systematic review and meta-analysis, RCTs reporting rebound pain and use of dexamethasone in the context of a peripheral nerve block were searched in various databases and updated in May 2023. The primary outcome was the incidence of rebound pain; secondary outcomes included the severity and time to onset of rebound pain, patient satisfaction with pain control, sleep disturbance because of pain, and adverse effects of dexamethasone. Subgroup analysis was conducted based on the effect of route of administration (intravenous or perineural) on the incidence of rebound pain. Trial sequential analysis was performed to rule out the possibility of a false positive result. RESULTS: Seven RCTs comprising 574 patients were included in this review. The dexamethasone group was associated with a reduction in the incidence of rebound pain with an odds ratio of 0.16 (95% confidence interval 0.10-0.27, P=0.00, I2=0%) compared with the control group. Trial sequential analysis confirmed the adequate information size for the beneficial effect of dexamethasone. Subgroup analysis showed that both intravenous and perineural administration were associated with a significant reduction in the incidence of rebound pain. CONCLUSIONS: Current evidence suggests that both intravenous and perineural dexamethasone reduce the incidence of rebound pain after a peripheral nerve block provided for postoperative analgesia. SYSTEMATIC REVIEW PROTOCOL: PROSPERO CRD42023424031.
引用
- Singh NP, Makkar JK, Chawla JK, et al. Prophylactic dexamethasone for rebound pain after peripheral nerve block in adult surgical patients: systematic review, meta-analysis, and trial sequential analysis of randomised controlled trials. Br J Anaesth. 2023. PMID: 38501226. doi:10.1016/j.bja.2023.09.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。